Viral Suppression in People With HIV Receiving Long-Acting Lenacapavir or Cabotegravir
-
By
-
Nathanael L. Gistand
-
Ishaan C. Mishra
-
Kyle Hunter
-
Megan J. Heise
-
Chesa Cox
-
Janet Grochowski
-
Francis Mayorga-Munoz
-
Jon Oskarsson
-
Mary Shiels
-
Matthew A. Spinelli
-
Monica Gandhi
-
October 8, 2026